During the government shutdown, public health experts talked political and monetary hurdles, and fostering community amid ...

Other CIBMTR presentations will include additional results from ACCESS study; a trial in progress update on the ACCELERATE trial (NCT06859424), a platform protocol for testing multiple PTCy-based ...

The reform, approved by the Illinois General Assembly and championed by Giannoulias and state Sen. Elgie Sims, raises the ...

Poster presentations will preview new data from breakthrough bloodstream infection detection and oncology tests running on first-of-its-kind  Lilia-SEQ™ ...

As you may know, if you’ve been following our Board meetings, biweekly Friday E-Village Items (by email or on the Village ...

Incyte today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual Meeting, to be ...

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

Oh my God, OK, it’s happening! From social-media posters to the F.C.C. chair, we are all living in Michael Scott’s world.

Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both primary and metastatic breast cancer, announced today that its ...

The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green CNS(Vafidemstat) Received feedback ...

Total committed capital of US $140m for restart of Bogoso and Prestea mine secured from two separate institutional backers (US $75m Equity Line of Credit, still undrawn, and new US $65m1 secured loan) ...